Quick Answer
aTYR PHARMA INC reported Earnings Per Share Diluted of $0.80 (loss) per share for the year ending 2025.
- aTYR PHARMA INC showed an increase of +7.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from aTYR PHARMA INC's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), aTYR PHARMA INC's Earnings Per Share Diluted has grown by 54.8%.
- Historical annual values: Fiscal year 2025: $0.80 (loss) per share | Fiscal year 2024: $0.86 (loss) per share | Fiscal year 2023: $0.94 (loss) per share | Fiscal year 2022: $1.60 (loss) per share | Fiscal year 2021: $1.77 (loss) per share | Fiscal year 2020: $1.77 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: